• Home
  • >>>>>>>>>>>>> 2026 & BEYOND MASTER PLAN >>>>>>>>>>>>>>>>
  • Virtual Data Room (VDR) for Strategic Customized Slide Decks
  • TRAINABLE DATA ASSETS IN CORPORATE LEGACY & ORGANIZATION’s STRATEGIC MEMORY (2012 – 2025)
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • Founder’s Vision
  • Portfolio of IP Assets
  • Knowledge PORTALS System (KPS)
  • 1.0 LPBI – 2012-2020 VISTA
  • LPBI Group’s History
  • 2.0 LPBI – 2021-2025 VISION
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder’s Bio
  • Funding, Deals & Partnerships
  • 1.0 LPBI Group News
  • 1.0 LPBI CALENDAR
  • 2.0 LPBI Group News
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2021 Summer Internship Portal
  • 2021-2025 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • Blockchain Transactions Network Ecosystem
  • 1.0 LPBI Brochure
  • 2.0 LPBI Brochure
  • 2.0 LPBI – Calendar of Zooms
  • Coronavirus, SARS-CoV-2 Portal
  • LPBI India
  • SOP Web STAT
  • Synthetic Biology in Drug Discovery
  • Certificate One Year
  • NFT: Redefined Format of IP Assets
  • Audio English-Spanish: BioMed e-Series
  • Five Bilingual BioMed e-Series
  • Press Releases
  • Intangibles CIM
  • BioMed Audio Podcast Library @LPBI Group
  • Medical School Education: Use of LPBI Group’s Contents
  • ChatGPT + Wolfram PlugIn
  • Medicine with GPT-4 & ChatGPT
  • AGI, generativeAI, Grok, DeepSeek & Expert Models in Healthcare
  • Multimodal Healthcare Foundation Model
  • Cell Therapy in Regenerative Medicine, 2026 and Beyond
  • Contact Us

Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA

Healthcare analytics, AI solutions for biological big data, providing an AI platform for the biotech, life sciences, medical and pharmaceutical industries, as well as for related technological approaches, i.e., curation and text analysis with machine learning and other activities related to AI applications to these industries.

Feeds:
Posts
Comments

Comparative Analysis of the Level of Engagement for Four Twitter Accounts: @KDNuggets (Big Data) @GilPress @Forbes @pharma_BI @AVIVA1950

Comparative Analysis of the Level of Engagement for Four Twitter Accounts:

  1. @KDNuggets Covering #AI, #Analytics, #BigData, #DataMining, #DataScience, #MachineLearning, #DeepLearning. Founded by computer scientist Gregory Piatetsky-Shapiro, PhD  the “Pioneering Father” of the Data Mining Discipline @GTE Labs in the mid 90s.
  2. @GilPress @Forbes Lead Reporter @Forbes on #Big Data, #Analytics, #AI and Blog launcher of http://whatsthebigdata.com/
  3. @pharma_BI Official Twitter Account of Leaders in Pharmaceutical Business Intelligence (LPBI) Group: e-Scientific Publishers
  4. @AVIVA1950 Professional Twitter Account of Aviva Lev-Ari, PhD, RN

The comparative analysis of Engagement includes outcomes on the following five indicators:

  • Number of Tweets
  • Number of Following
  • Number of Followers “Likes”
  • Ratio of “Likes” to Tweets
  • Ratio of Followers to Following

Data Updated on 8/3/2021

AccountTweetsLikesLikes:Tweets
Kdnuggets71,5008780.012
AVIVA195017,10010,5000.614
pharma_BI25,5003,0640.12
GilPress37,0003,2050.086
AccountFollowingFollowersFollowers:Following
KKD Nuggets430192,400446.511
AVIVA19502,2545480.243
pharma_BI8155230.641
GilPress3,93022,0005.597
As you can see from the graph above, AVIVA1950 receives significantly more likes per tweet than the other 3 users.
Looking at the ratio of accounts following each user selected and the number of accounts the users follow, it is clear that KDnuggets is by far the most followed account.

These graphs pose an interesting question when compared with one another. Despite having the most followers, KDnuggets receives the fewest likes per tweet. This is very surprising as they are the account that have the most followers by a significant margin. It would be interesting to see what types of accounts follow KDnuggets and explore potential explanations for this contradiction. Similarly, it would be important to look at the activity of AVIVA1950’s account and look at potential reasons why it is receiving more likes.

Data Updated on 4/15/2019

AccountTweets (thousands)Likes (hundreds)Likes:TweetFollowing (hundreds)Followers (hundreds)Followers:FollowListsInsights
Kdnuggets55.86.420.124.131450351.0914most followers, least likes, most tweets
AVIVA19509.0236.594.0514.623.910.27n/amost likes per tweet, least followers per follow, least tweets
pharma_BI24.830.881.258.385.140.61n/amost likes
GilPress34.624.990.7234.872176.222least likes per tweet
Extra Insights: more lists correlates to more followers, fewer tweets correlates to higher likes per tweet
     
     
AccountFollowing (hundreds)Followers (hundreds)Followers:Follow 
KKD Nuggets4.131450351.09 
AVIVA195014.623.910.27 
pharma_BI8.385.140.61 
GilPress34.872176.22 
     

 

 

The Higher the Ratio of “Likes” to Total Number of Tweets,

the Higher the Level of Engagement

Data retrieved on 2/24/2019

Graph prepared by Alex Crystal, University of Rochester ’22 Data Science Major

AccountTweetsFollowingFollowersLikes Likes:TweetFollowers:FollowInsights
@KDNuggets

 

#BigData,

#DataMining,

54,800410142,000631 0.0115346.34most followers, least “Likes”, most tweets, least “Likes” per tweet
@AVIVA1950

 

Among 362 Followers, am mostly honored to be followed by: Technion Israel, Broad Institute @MIT @Harvard, NFCR, Technion T³ BCM_CVRI, Discovery on Target (CHI), Partners Innovation (@MGH, @BWH), PM Conference @Harvard

8,13314193622912 0.35800.26most “Likes” per tweet, least followers per follow, least tweets,

 

Fewer tweets correlates to highest “Likes” per tweet

@pharma_BI24,6008365073033 0.12330.61most likes
@GilPress

 

@Forbes

34,500341921,6002461 0.07136.32 
         
  

SOURCE

@twitter.com

Other Related articles:

  • Mostly HONORED to be followed by [from an Excerpt of 117 Followers of the Twitter Account @AVIVA1950 from the List of 359 Followers by the Number of their Followers on 2/24/2019
  • Excerpt of 117 Followers of @AVIVA1950 (from the List of 359 Followers) by the Number of their Followers

Share this:

  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Facebook (Opens in new window) Facebook
  • Print (Opens in new window) Print
  • Email a link to a friend (Opens in new window) Email

Like this:

Like Loading…

  • Follow Blog via Email

    Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 2,041 other subscribers
  • Recent Posts

    • In Memoriam: In Remembrance of Cancer Researchers who passed in 2026 July 13, 2026
    • Urgent Request for Action on Proposed Rule Affecting Federal Funding Grant Review July 7, 2026
    • 2026 Tang Prize in Biopharmaceutical Science Awarded to Three Pioneers of Cellular Immunotherapy Revolutionizing Treatments for Blood Cancers and Solid Tumors July 5, 2026
    • Protected: KOL on Competitive Dynamics: LPBI Group’s Founder’s Radar Screens on AI in Health, Life Sciences & BioPharma June 15, 2026
    • Tumor Infiltrating Lymphocytes (TIL) as a first of kind FDA approved immunotherapy for cancer June 12, 2026
    • A Systematic Analysis of Competitive Dynamics in the AI Revolution — Strategic Relevance to LPBI Group’s Mission – Alex Wissner-Gross Daily Newsletters by KOL (March 1 – June 10, 2026, to be extended to Present) June 11, 2026
    • In Memoriam: Professor Yitzhak Apeloig, President and Distinguised Professor of the Technion June 4, 2026
    • Top VC Investors in AI / Health AI in 2026 May 26, 2026
    • Grok thinks like PhDs – Hybrid Model for Autonomous Update of Doctoral Dissertations with Original PhD Student Author editing and acceptance of Grok’s updated output. 3rd Joint article, a pilot study for Validation of an Autonomous Journal Articles Updating System (AJAUS) tested on Autonomous Update of Aviva Lev-Ari, PhD, RN Doctoral Thesis, UC, Berkeley, 1983. January 31, 2026
    • 2026 World Economic Forum, 1/19 – 1/23/2026, Davos, Switzerland, LPBI Group’s KOLs interpretation of AI in Health Videos January 24, 2026
  • Archives

  • Categories

  • Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • 1 2012pharmaceutical
    • 1 sjwilliamspa

Powered by WordPress.com.

WPThemes.


Loading Comments...

    %d